Sectors
DARE
Daré Bioscience, Inc.
0.77
2 x 0.61
2 x 1.09
bid
ask
+
0.00
0.16%
2 @ 06:17 PM
0.77 -0.00 (0.14%)
| Ytd | -59.93% | |
| 1y | -65.32% |
0.76
day range
0.79
0.70
52 week range
3.27
| Open | 0.79 | Prev Close | 0.77 | Low | 0.76 | High | 0.79 | Mkt Cap | 15.21M |
| Vol | 70.04K | Avg Vol | 525.06K | EPS | -0.71 | P/E | N/A | Forward P/E | -2.35 |
| Beta | 1.34 | Short Ratio | 0.64 | Inst. Own | 7.59% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-12 | 50-d Avg | 0.90 | 200-d Avg | 1.69 | 1yr Est | 21.33 |
| Income Statement | |||
| Total Revenue | 187.55K | ||
| Revenues (USD) | 187.55K | ||
| Cost of Revenue | 319.89K | ||
| Gross Profit | -132.34K | ||
| Operating Expenses | 2.84M | ||
| Research and Development Expense | 241.97K | ||
| Selling, General and Administrative Expense | 2.59M | ||
| Operating Income | -2.97M | ||
| Net Income | -2.98M | ||
| Net Income Common Stock | -2.98M | ||
| Net Income Common Stock (USD) | -2.98M | ||
| Consolidated Income | -2.98M | ||
| Earnings per Basic Share | -0.20 | ||
| Earnings per Basic Share (USD) | -0.20 | ||
| Earnings per Diluted Share | -0.20 | ||
| Earning Before Interest & Taxes (EBIT) | -2.98M | ||
| Earning Before Interest & Taxes (USD) | -2.98M | ||
| Weighted Average Shares | 14.89M | ||
| Weighted Average Shares Diluted | 14.89M | ||
| Balance Sheet | |||
| Cash and Equivalents | 12.62M | ||
| Cash and Equivalents (USD) | 12.62M | ||
| Trade and Non-Trade Receivables | 456.43K | ||
| Current Assets | 16.69M | ||
| Property, Plant & Equipment Net | 3.13M | ||
| Total Assets | 22.37M | ||
| Debt Current | 743.87K | ||
| Total Debt | 1.02M | ||
| Current Liabilities | 16.92M | ||
| Debt Non-Current | 273.87K | ||
| Total Liabilities | 22.93M | ||
| Accumulated Retained Earnings (Deficit) | -194.67M | ||
| Accumulated Other Comprehensive Income | -374.86K | ||
| Shareholders Equity | -560.10K | ||
| Shareholders Equity (USD) | -560.10K | ||
| Assets Non-Current | 5.68M | ||
| Total Debt (USD) | 1.02M | ||
| Liabilities Non-Current | 6.01M | ||
| Trade and Non-Trade Payables | 762.91K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 703.80K | ||
| Net Cash Flow from Financing | 951.22K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -5.90M | ||
| Capital Expenditure | -80.59K | ||
| Issuance (Purchase) of Equity Shares | 166.70K | ||
| Issuance (Repayment) of Debt Securities | -448.18K | ||
| Net Cash Flow from Investing | -80.59K | ||
| Net Cash Flow from Operations | -6.78M | ||
| Effect of Exchange Rate Changes on Cash | 2.23K | ||
| Share Based Compensation | 286.60K | ||